Chai Discovery, an AI biology startup founded six months ago, has raised nearly $30 million from heavyweights Thrive Capital and OpenAI to bring AI to drug discovery. Chai Discovery CEO Josh Meier joins Ed Ludlow and Caroline Hyde to discuss on “Bloomberg Technology.” (Source: Bloomberg)
Read the full article here